Stay updated on Pembrolizumab for Meningioma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab for Meningioma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab for Meningioma Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    Added site revision label v3.5.0 and removed the previous label v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-19T05:20:57.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-12T00:29:26.000Z thumbnail image
  5. Check
    54 days ago
    Change Detected
    Summary
    The page now shows a new site revision tag: Revision: v3.4.2, and the earlier funding-status notice and Revision: v3.4.1 tag have been removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T12:47:21.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    A banner notice about a lapse in government funding and related operating-status information was added; the revision was updated to v3.4.1 with new dates (2026-01-29, 2026-01-21, 2026-01), and the previous revision v3.4.0 was removed.
    Difference
    0.6%
    Check dated 2026-02-04T06:54:57.000Z thumbnail image
  7. Check
    68 days ago
    Change Detected
    Summary
    UI/metadata updates include a new glossary display label, updated QC-related date fields (Last Update Submitted that Met QC Criteria and Last Update Posted), the No FEAR Act Data label, and a revision bump to v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-01-28T04:32:35.000Z thumbnail image
  8. Check
    82 days ago
    Change Detected
    Summary
    Revision of Study Documents updated from v3.3.3 to v3.3.4; this appears to be a minor administrative update with no impact on eligibility criteria, trial results, or contacts. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T01:35:21.000Z thumbnail image

Stay in the know with updates to Pembrolizumab for Meningioma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Meningioma Clinical Trial page.